EP-475

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1972-2008
01219722008

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Cyclophosphamide 1.5–2.0-fold increased activity of cathepsins B and L in tumor tissue of mouse lymphosarcoma LS and caused tumor… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
Is this relevant?
1996
1996
Analogs of the epoxysuccinyl peptide cysteine proteinase inhibitor, EP-475 (2a), in which the free carboxylate has been replaced… (More)
Is this relevant?
1986
1986
When rat muscles were incubated in Ca2+-free media, their rates of protein break-down were significantly lower than in complete… (More)
Is this relevant?
1984
1984
Infiltration of compound eyes of crayfish, Cherax destructor, with the thiol protease inhibitor Ep-475 or with trifluoperazine… (More)
  • figure 6
  • figure 8
  • figure 11
  • figure 12
  • table I
Is this relevant?
1984
1984
The end-plate of a mammalian skeletal muscle fibre is innervated by several axons at the time of birth but by only one axon in… (More)
Is this relevant?
Highly Cited
1983
Highly Cited
1983
To clarify the mechanisms underlying the loss of body protein during fever and sepsis, we incubated rat muscles with highly… (More)
Is this relevant?
Highly Cited
1982
Highly Cited
1982
1. L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) at a concentration of 0.5 mM had no effect on the serine… (More)
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
1982
1982
The effects on protein degradation of the thiol proteinase inhibitor E-64 of fungal original, and its two synthetic analogs Ep… (More)
Is this relevant?
1982
1982
The distal regions of the photoreceptor microvilli of tipulid flies are shed to extracellular space during membrane turnover… (More)
  • figure 2
Is this relevant?
1981
1981
Modification of E-64 focused on the terminal agmatine for practical use led to some potent analogs which were successfully… (More)
Is this relevant?